RxDoctor Payments Data

Alyssa Comerford, PA

Surgical · Chesterton, INNPI 1952173932

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,440 of the $2,772 with a category attached, or 88.0%. It is spread thinly across 18 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. Among surgical clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,772in general payments, 2019–2025

Across 128 payments — averaging $21.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$428
  • UCB, Inc.$296
  • Galderma Laboratories, L.p.$281
  • Novartis$266
  • Johnson & Johnson$259
  • Incyte Corporation$219
  • plus $1K from 12 others

What the payments were for

  • Food & beverage$2,44088%
  • Education$33212%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,772 in reported general payments places this provider in the 90th percentile of 130 surgical providers in Indiana.

See all surgical providers in Indiana

Medicare billing

Part B allowed, 2024
$21,592
Medicare patients
102
Services billed
436

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate16$1,010
Triamcinolone Acetonide39$411
Ketoconazole28$359

Paid to pharmacies, not to this prescriber.

Other surgical in Chesterton

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →